(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

KANGSTEM BIOTECH

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

KANGSTEM BIOTECH

ST13

US500000079197023

Classe

3, 5, 42

Pedido

79197023

Registro

5361909

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

39

Atualização mais recente

21/06/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

3, 5, 42

Data de depósito

20/07/2016

Data de registro

26/12/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/07/2024

Última transação

21/06/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

03

Localização do titular

Seoul, KR

Examinador

CARROLL, DORITT

Unidade examinadora

M70

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the wording "KANGSTEM BIOTECH" underneath Korean characters.

Titulares e representantes

Titulares

Kangstem Biotech CO., LTD.

Representantes

KIM, HEE SO KIM, HEE SO

Classificação técnica

Classes Nice

Classe 3Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 3

Body lotion; body milk; skin lotions; cosmetic creams for skin care; cosmetic preparations for skin care; skin cream; skin cleansers; eye cream; facial lotions; facial cream; face milk and lotions; face and body lotions; face and body milk; cosmetics for the face and body; lotions for face and body care; face and body creams; lotions for cosmetic purposes; cosmetics; cosmetic skin milk lotions

Classe 5

Pharmaceutical preparations for immunity adjustment; vaccines; cord blood for medical use; allergy medications; Skin lotions for pharmaceutical purposes; ointments for pharmaceutical purposesantibiotic ointmentsanti-inflammatory ointmentsanti-itch ointment; chemico-pharmaceutical preparations for the treatment of cancer; pharmaceutical agents for epidermis; microorganism preparation for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; stem cells for medical purposes; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the treatment of cells; preparations for treatment of cancer; biological preparations for medical and clinical purposesbeing extracted from stem cellsstem cell tissuesstem cell tissue scaffolds and the combinations thereofall for the treatment of cancer; drugs for medical and clinical purposesbeing extracted from stem cellsstem cell tissuesstem cell tissue scaffolds and the combinations thereofall for the treatment of cancer; pharmaceutical preparation for treatment of auto-immune diseases; stem cell medicine; bouillons for stem cultures

Classe 42

Cosmetology research; research and development of vaccines and medicines; biotechnology research; advisory services relating to biotechnology; research on cancer; pharmaceutical products development; research on the subject of pharmaceuticals; research in the field of gene analysis; genetic research; research for medical products; medical research; product safety testing; quality control for others; cosmetic research; research services in the field of cosmetics; survey services in the nature of technical consulting regarding pharmaceutical studies in the field of cosmetics; development of cell therapy products; stem cell collection for medical research purposes; stem cell testing for medical research purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

39 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

20/06/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

31/05/2025

INPC

INVALIDATION PROCESSED

31/05/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

12/03/2025

C71T

CANCELLED SECTION 71

12/07/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

07/11/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

19/05/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

30/03/2018

FIMP

FINAL DISPOSITION PROCESSED

30/03/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

26/03/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

26/12/2017

GPNX

NOTIFICATION PROCESSED BY IB

21/10/2017

PUBO

PUBLISHED FOR OPPOSITION

10/10/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/10/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/10/2017

NPUB

NOTICE OF PUBLICATION

20/09/2017

CNEA

EXAMINERS AMENDMENT MAILED

05/09/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

01/09/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/09/2017

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/09/2017

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

22/08/2017

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

10/08/2017

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

28/07/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

17/07/2017

DOCK

ASSIGNED TO EXAMINER

16/07/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/06/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/06/2017

ALIE

ASSIGNED TO LIE

08/06/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/05/2017

RFNT

REFUSAL PROCESSED BY IB

30/12/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/12/2016

RFRR

REFUSAL PROCESSED BY MPU

12/12/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/12/2016

CNRT

NON-FINAL ACTION WRITTEN

10/12/2016

MAFR

APPLICATION FILING RECEIPT MAILED

06/12/2016

DOCK

ASSIGNED TO EXAMINER

02/12/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/12/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/12/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace KANGSTEM BIOTECH ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.